A Dose Escalation Study of STA-9090 and Docetaxel in Patients With Solid Tumors

Clinical trial NCT01183364 · COMPLETED

Trial details

NCT number: NCT01183364
Sponsor: Synta Pharmaceuticals Corp.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Malignancies

Start date: 2010-07-01
Primary completion: 2013-03-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.